Posts Tagged 'zostavax'

Access to Shingrix May Come Down to Where You Look

Shingrix vaccine may be in short supplyIt’s been a good year for GlaxoSmithKline. Just one year after its Shingrix shingles vaccine was approved by the FDA, the drug is in such high demand that availability has become an issue and the drug manufacturer is ramping up production to meet the growing need.

“We understand that this is a challenging situation to manage, and GSK is fully committed to expediting resupply throughout 2018. Going forward, providers and patients ...

continue reading...

When It Comes to Shingrix vs. Zostavax, the CDC Makes Their Preference Clear

cdc recommends Shingrix over ZostavaxOn a page titled “What Everyone Should Know about Zostavax,” the CDC would like you to know that they’d prefer that you use Shingrix instead.

Until recently, the only vaccine available for the prevention of shingles was Zostavax; a position it had enjoyed since being approved for use in 2006. Shingles comes from the same virus that causes chickenpox; a fact that is highly emphasized in Zostavax’s marketing campaign. If ...

continue reading...

Merck Moves to Consolidate as Zostavax Lawsuits Multiply

zostavax cases consolidated to MDLNow facing close to 60 lawsuits over its shingles vaccine Zostavax, Merck has petitioned for an MDL, or multidistrict litigation, to be created to help resolve the cases. 57 Zostavax lawsuits currently span nine federal courts, and the corporation only expects that number to grow. The lawsuits stem from allegations that Zostavax – marketed under the promise of preventing shingles – can actually cause the condition instead.

Zostavax is recommended ...

continue reading...

Zostavax Label Updated to Reflect Shingles Virus Risk

Zostavax label receives subtle yet important updateThe contraindication section of the label for shingles vaccine Zostavax recently received a subtle, yet important, update.

The previous label made no direct mention of the fact that, if taken by someone who has a suppressed or inactive immune system, Zostavax could actually cause shingles in the vaccinated patient. This is an important point, as the patient would be administered the vaccine specifically to avoid the painful – and potentially life-threatening ...

continue reading...

Zostavax Competitor Wins Unanimous Recommendation for Approval

shingrix wins approval recommendationAfter considering the data, every member of an FDA advisory panel convened this month voted to recommend the approval of Shingrix – a new shingles vaccine developed and marketed by GlaxoSmithKline.

Data was not based solely on efficacy, or effectiveness. Rather, the data also took the vaccine’s safety into consideration. Panel members were “very impressed” with that data on both fronts and – according to Reuters – believe that Shingrix is ...

continue reading...

New Lawsuit Claims Zostavax Shingles Link

Zostavax linked to causing shinglesA lawsuit filed in mid-July seeks compensation and damages for 18 patients who claim that Merck’s anti-shingles vaccine Zostavax actually gave them the condition they were seeking to avoid. Hailing from a variety of states, the plaintiffs have come together to sue Merck in its home state of New Jersey.

Zostavax is targeted at people aged 50 years or older and the CDC has gone so far as to issue ...

continue reading...
Page 1 of 2 12